Female Sports Supplements: Emerging Science Drives Bespoke Formulation Opportunities

London, United Kingdom — 23 July 2026

Supplement industry research consistently underrepresents female physiology, leading to product recommendations often extrapolated from male-dominated data. However, a growing body of science points to the necessity of individualised strategies that account for sport demands, training phases, age, body composition goals, hormonal status, and menstrual cycle phases in female athletes. This shift from generic formulations to bespoke protocols represents a significant commercial opportunity for manufacturers and brand owners.

Protein-based strategies, particularly when combined with resistance training, show clear efficacy in supporting lean mass, muscle function, and healthy ageing in women. Collagen is gaining traction for its potential role in tendon, bone, and appetite regulation, though further research is ongoing. Creatine, while generally safe and effective for strength and power, requires more female-specific guidance. Caffeine demonstrates promise for cognition and explosive tasks, while adaptogens like ashwagandha and advancements in gut health research signal a broader trend towards recovery, stress management, and personalised performance support.

The FIFA Female Health Project, highlighted in Sports Medicine, exemplifies this trend by synthesising current research to develop nuanced nutritional strategies for women's soccer. Recommendations emphasise adequate energy intake, strategic carbohydrate timing, and individualised hydration, considering factors like playing position, training volume, and menstrual status. This signals a future where generic sports nutrition will be insufficient, pushing demand for sophisticated, data-backed female formulations.

Further studies indicate that older women may benefit significantly from combining exercise with essential amino acids to enhance muscle growth and fitness, as published in the Journal of the International Society of Sports Nutrition. Similarly, a pilot study in Frontiers in Nutrition, featuring Vital Proteins' collagen peptides, showed positive modulation of bone formation and inflammation markers in premenopausal female endurance athletes. This suggests distinct targeting for different female demographic segments based on age and physiological demands.

A review from Beijing Sport University indicates multi-ingredient protein supplements (MIPS) can improve fat-free mass and muscle strength in women when combined with exercise, with outcomes moderated by age and intervention duration. Additionally, research in Sport Nutrition and Exercise Metabolism noted that collagen supplementation improved tendon remodelling and explosive performance in elite female Master field hockey athletes. These findings underscore the need for ingredient suppliers and brand owners to invest in female-centric efficacy trials to validate claims and differentiate products.

Reviews on caffeine's impact on female intermittent-sport athletes suggest improved agility and vertical jump performance, while research in Nutrients on KSM-66 ashwagandha points to sex-specific benefits in managing physiological stress during demanding training periods. These insights offer clear pathways for targeted product development and marketing for specific athlete populations.

What this means for United Kingdom

UK brand owners must prioritise female-specific product development to capture a growing market segment. Reformulation efforts should focus on precise dosing and ingredient combinations validated by female physiology research, particularly for protein, collagen, and adaptogens. Compliance with MHRA and FSA guidelines for female-specific claims will be critical, necessitating robust scientific dossiers. Brands investing in bespoke female sports nutrition can expect to see increased market penetration in retailers like Boots and Holland & Barrett, leveraging consumer demand for credible, tailored solutions. This also extends to contract manufacturers, who should prepare for bespoke MOQ's for new, female-focussed formulations. Procuring ingredients with proven female efficacy, such as specific collagen hydrolysates or KSM-66 ashwagandha, will become a competitive differentiator, potentially reducing formulation windows and accelerating speed to market.

Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.